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Introduction
Calotropis gigantea (C.gigantea) is a plant that grows 
wild and is widespread in Indonesia. For generations, 
this plant has been traditionally used by the people of 
Indonesia to cure rashes, scabies, boils, cough, trachoma, 
constipation (the leaves), asthma, nausea, stomach pain 
(the flowers), syphilis, viper bites (the roots), toothache, 
swelling, ear inflammation, intestinal worms infestation 
and dysentery (Radjakmanugunsudarso 1968). Scientific 
evidence on anticancer activity happening in this plant 
has been reported to include calotropon compound of the 
roots that induce cytotoxic activity against leukemia cell 
K562 and gastric cancer cells 7901 (Wang et al., 2008). 
The methanol extract and chloroform fraction of its 
flowers induce antitumor activity on mice to fight ascites 
carcinoma (Habib et al., 2010). The methanol extract 
(ME) and chloroform fraction of the roots of C. gigantea 
is capable of inhibiting the growth of ascites carcinoma 
by 43.90% (20mg ME/kg) and 57.07% (40mg CF/kg) 
(Habib and Karim, 2011). It has been reported that the 
cytotoxic potential of the leaves’ cardenolide compound 
can inhibit the growth of breast cancer cell MCF-7, 
skin cancer cells KB, and lung cancer cells NCL-H18 
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(Seeka and Sutthivaiyakit 2010). The dichloromethane 
cytotoxic extracted from the leaves is potential to fight 
breast cancer cells MCF-7 and MDA-MB-231, Hela cells, 
colon cancer cells HT-29, ovarian cancer cells Skov-3 
and also liver cancer cells Hep-G2 (Wong et al., 2011) .
In previous studies, it has also been reported that 
the ethanol extracted from C. gigantea leaves was 
capable of inhibiting the in vivo growth of fibrosarcoma 
at the dose of 100 and 150 mg/kg with an increased 
expression mechanism of caspase-3 (Muti et al. 2016). 
C.gigantea root extract contained higher anticancer 
activity than its leaves and flowers (Mutiah et al., 2016). 
The ethyl acetate fraction of the leaves (IC50 41.79 μg/ml) 
and its dichloromethane fraction (IC50 40.57μg/ml) had 
higher cytotoxic activity than those of butanol fraction 
(IC50 737.74 μg/ml) and water (IC50 8493 μg/ml) (Mutiah 
et al., 2017).
In a preliminary test on the fractionated ethanol 
extract of the roots of calotropis gigantea, the ethyl 
acetate fraction (IC50 0.063 μg/ml) showed higher 
cytotoxic activity than that of dichloromethane fraction 
(IC50 0.367 μg /ml), butanol (IC50 12:18 g/ml) and water 
(IC50 8493μg/ml). Based on these data, it can be seen that 
the ethyl acetate fraction of C. gigantea’s roots performed 
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a higher anticancer activity than the other fractions. It was 
presumed that the ethyl acetate fraction contained in 
the active compound was responsible for the anticancer 
activity on the roots of C. gigantea. Therefore, it is 
important to conduct further research on the ethyl acetate 
fraction on C gigantea’s roots, which is mainly related to 
the active compounds comprised in these fractions and 
the operating mechanism of the active compound.
In this study, an isolation on anticancer compound 
from ethyl acetate fraction of the roots of C. gigantea 
had been conducted which was active towards WiDr 
colon cancer cells. The isolation was conducted by 
using bioassay guided isolation approach method. 
The isolation was conducted based on anticancer activities, 
ranging from fractions, sub-fractions and isolates. Then, 
the chemical structures of the active isolates were 
determined. This research is important because there are 
still many active anticancer compounds from the roots of 
C. gigantea which are left undiscovered. In addition, 
the approach taken by previous researchers have not 
been based on bioassay guided isolation. This step 
is important to take as it determines the compounds 
responsible for anticancer activity (lead compounds) 
contained in the roots of C. gigantea.
Materials and Methods
Experiment Method
Materials, equipment and reagents
Materials and reagents
The research materials: The plant employed in this 
study was C. gigantea taken from Malang, East Java. 
The plant parts used were the roots. The roots were dried 
in an oven at a temperature of 40oC. The dried simplicia 
was then ground into powder and put in a dry brown bottle.
Materials for the extraction, fractionation, and 
isolation of the active compound of C. gigantea roots: 
The solvent used for ethanol extraction on the maceration 
stage was technical ethanol, while the one used in 
fractionation stage was distilled water, dichloromethane 
p.a (Merck), ethyl acetate p.a (Merck), and butanol p.a 
(Merck). The materials for sub-fractionation and isolation 
were n-hexane p.a, (Merck) ethyl acetate p.a (Merck), 
chloroform p.a (Merck), ethanol p.a (Merck), acetonitrile 
p.a (Merck), Methanol pro HPLC (JT Backer), pro HPLC 
acetonitrile (JT Backer), TLC plates of silica gel 60 F254 
(Merck 0.25 mm), silica gel 60 for chromatography 
column (Merck 0.063 to 0.200 mm), and last silica gel 
60G (Merck).
Materials for cell culture: The cancer cells used 
in this study were colon cancer cell lines. The colon 
cancer cells used were WiDr cells obtained from the 
Cancer Chemoprevention Research Centre (CCRC) of 
Faculty of Pharmacy of Gadjah Mada University and 
from Prof. Masasi Kawaichi from the Laboratory of 
Gene Function in Animal, Graduate School of Biological 
Sciences, Nara Institute of Science and Technology. 
WiDr cells in a medium of Rosewell Park Memorial 
Institute (RPMI) were added with 10% of heat-activated 
fetal bovine serum (FBS) (PAA laboratories), 1% v/v 
penicillin-streptomycin (Nacalay Tesque), and 1.0 mM of 
L-glutamine (Nacalay Tesque). All cells were cultured in 
an incubator at 5% of CO2, in 37 oC.
Cytotoxic test materials: Dimethyl sulfoxide 
(DMSO) was used to dissolve C. gigantea extract. 
The concentration used in this study was maximum 1% 
in the culture medium, 0.025% trypsin in the culture 
medium was used to harvest the cells. Phosphate 
buffered saline (PBS) was used as wash buffer solution. 
3-(4.5-dimetiltiazole-2-il)-2.5-difeniltetrazolium 
bromide (MTT) was used as a reagent that reacted with 
the succinate dehydrogenase enzyme in the cells.
Materials for cell cycle regulation testing using Flow 
Cytometry method: A solution of propidium iodine (PI) 
(Sigma) comprising of 50μg/ml PI, 20μg/ml, and 0.1% 
Triton-X (Pro GC-Merck) in PBS was used. Filters were 
used to filter out cells in a solution of PI to be separated 
into single cells.
Materials for apoptosis induction test using flow 
cytometry method: A solution of propidium iodine (PI) 
(Sigma) consisting of 50μg/ml PI, 20μg/ml, and 0.1% 
Triton-X (Pro GC-Merck) in PBS was used. AnnexinV 
assay (Annexin V-FITC Apoptosis Detection Kit 
Biovision) and binding buffer were used.
Equipment
The instruments for the processes of extraction, 
separation, isolation and purification of active compounds 
include glassware, rotary, analytical scale, vacuum 
columns, open columns, chambers, vials, spray stains, 
capillary tubes, fume hoods, TLC Visualizer (Camag), 254 
and 365nm UV lights (Camag), high performance Liquid 
Chromatography (Shimadzu LC-06), RP shim-pack 
columns 4.6x250 mm, Prominanence DGU-20A5 
degasser, Pump LC-6AD, shim-pack column 4,6x250 mm, 
Prominence DiodeArray Detector SPD-M20A.
The instruments for the cytotoxicity test and 
the operating mechanism: CO2 incubator (New Bronswick, 
Galaxy 170 R), centrifuge (Hermle Siemensstr-25 D-78 
564), sonicator, Laminar Air Flow cabinet (Mascotte LH-S), 
a micropipette (soccorex), autoclave, hemocytometer, 
inverted microscope (Olympus CKX41-2), ELISA reader 
(Robonik), flow cytometer.
The instruments to identify the active ingredient and 
active compound: NMR JEOL Spectrometer with radio 
wave frequency of 400 Hz (JNM-ECS400), a set of 
UPLC- QToF-MS/MS instrumentation system (waters).
Methods
Extraction
A total of 5kg of C. gigantea root powder was macerated 
using 14.5 liters of 70% ethanol for 48 hours. Then, it was 
filtered and the filtrate was then separated. The residue 
was then dried and re-macerated with 14.5 liters of 70% 
ethanol for 48 hours. This process was repeated for four 
times. After that, the filtrate was collected and evaporated 
in a vacuum rotary evaporator to obtain a thick extract. 
The condensed extract was then dried in an oven at 40°C. 
Then, 100 ml of distilled water was added to the extract 
and then mixed to obtain liquid ethanol extract. The extract 
was then fractionated by using dichloromethane 100:500 
(ethanol extract: dichloromethane) and two fractions 
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mode (ES +) electrosprayers; gas flow 794L/min.
Identification with NMR-1 H Spectroscopy
Approximately 3mg of isolates were dissolved 
in 0.5ml of CDCl3 and then put into a sample tube. 
Tetramethylsilane (TMS) was added to the solution as 
an internal reference. Then, the instrument was stationed 
between two magnetic poles where the spectrum was 
recorded.
Anticancer Activity Assay (MTT Method)
Cytotoxic Test with MTT method
As much as 100 mL of WiDr colon cancer cell 
suspension at a density of 3×104 cells/100 mL media 
was distributed into wells on 96-well plate and then 
incubated for 24 hours. After incubation, the wells were 
put into a 100 mL test solution at various concentration 
series. As a positive control, 100 mL of culture medium 
was added, followed by 100 mL of cisplatin on various 
concentration series in wells already containing 100mL 
cell suspension. As a control cell, 100 mL of culture 
medium was added in wells containing 100 mL of cell 
suspension while 100 mL of DMSO was added in wells 
containing 100 mL of culture medium and 100 mL of cell 
suspension as a control solvent with the delusions which 
matched the concentration delusions of the test solution. 
Then, these substances were incubated for 24 hours in 
an incubator with a stream of 5% CO2 and 95% O2. At 
the end of the incubation, culture medium was discarded 
and then 10mL solution of MTT (5 mg/mL PBS) was 
added, and the medium was replaced with 190mL of 
complete medium RPMI 1,640. Then, the cells were 
incubated for 3-4 hours. MTT reaction was stopped by 
adding SDS stopper reagent (100 mL). The microplates 
were then wrapped with tissue paper and incubated for 1 
night at room temperature with dark lighting. The living 
cells reacted to MTT to form purple stain. The test result 
was then read by ELISA reader at a wavelength of 595nm 
(Nugroho, 2013) .
Cell cycle analysis by Flow Cytometry
In cell cycle analysis, propidium iodide (PI) staining 
was used. This dye can be used to analyze a set amount of 
DNA in each cell. AS many as 5x105 cells/wells were 
implanted in 6-well plates and then incubated until 
the cells went back to normal. The cells were treated 
with DMSO (0.25%) solvent and active isolates at IC50.
The cells were then incubated for another 24 hours. 
At the end of the incubation period, the media were taken 
and then transferred to the centrifuge tubes (2,000 rpm 
for 3 minutes) where the supernatant was then discarded. 
In wells whose medium had been taken, PBS was 
added and then transferred to the same microtubes from 
the same treatment. Then, they were centrifuged where 
the supernatant was then discarded. This stage was repeated 
once again and then the cells were harvested with trypsin. 
The cells were then transferred into the same microtubes 
which then centrifuged (2,000 rpm for 3 minutes). 
The residue of cell harvest in the wells was then rinsed 
with PBS and underwent centrifuge again where then 
the PBS was discarded. The cell residue in the microtubes 
were yielded; soluble and insoluble dichloromethane 
fractions. The soluble dichloromethane fraction was then 
fractionated with ethyl acetate with the ratio of 100:600 
(insoluble dichloromethane fraction: ethyl acetate) thus, 
resulting ethyl acetate insoluble fraction and ethyl acetate 
soluble fraction. The ethyl acetate insoluble fraction was 
re-fractioned with butanol solvent with the ratio of 100:600 
(dichloromethane insoluble fraction: ethyl acetate). Thus, 
the ethyl acetate soluble fraction and water fraction were 
obtained. The four fractions were evaporated with a rotary 
evaporator to get a concentrated extract. The fractions was 
then dried in an oven at a temperature of 40°C.
Isolation and Purification
The Separation of Ethyl Acetate Fraction by Using 
Column Vacuum Chromatography 
The ethyl acetate fraction was separated using column 
vacuum chromatography with stationary phase silica 
gel G 60 where the mobile phase solvent gradient was 
based on the polarity degree (chloroform and methanol 
solvent gradients with 10% reduction, starting from 100% 
Chloroform up to 100% methanol). On each the resulted 
sub-fraction, thin layer chromatography using stationary 
phase silica gel F254 and mobile phase chloroform: 
methanol (9:1) were conducted. The TLC profiles were 
then observed with 254 nm and 366 nm UV lamps with 
10% sulfuric acid used as stain surface. The sub-factions 
resulting the same profiles were then grouped together, 
evaporated and weighed. Cytotoxicity assay was 
performed on the resulted sub-fractions by using WiDr 
human colonic cells. The most active sub-fraction found 
would undergo further separation.
Active Sub-fraction Separation by Open Column 
Chromatography 
The active sub-fractions were then separated with 
open column chromatography by using a stationary phase 
silica gel 60 and a mobile phase solvent gradient based on 
optimized polarity (n-hexane: ethyl acetate 4:1 and 2:8); 
ethyl acetate: chloroform (9:1) chloroform: methanol 1: 
1, methanol). The Stationary phase was 25 cm tall with 
a diameter of 3.8 cm. On each vial bin resulted, thin layer 
chromatography was conducted using stationary phase 
silica gel F254 and mobile phase hexane: ethyl acetate 
(4:1) and chloroform: methanol (9:1). The TLC profile 
was observed with 254 nm and 366 nm UV lamps while 
the stain surface used was 10% sulfuric acid. The isolates 
producing single stains would be followed up by further 
chemical structure identification. Isolates that did not 
show any stain would be followed up by purification 
using preparative TLC.
Active Compound Identification with UPLCMS/MS
The identification of SF 3.4.2 isolate was conducted 
using UP-LCMS/MS device with the type of ACQUITY 
UPLC I-Class (Waters) with a diode-array detector (DAD) 
2,996 (waters);column: Sunfire C18 sizing 50mm long, 
with 2 mm diameter and μm particle size (waters). Mobile 
phase: acetonitrile gradient; water; Formic acid, 1ml/min 
flow rate, injection volume 10 μl. MS system Xevo G2-S 
QTOF (waters), analyzer: TOF with positive and negative 
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were then fixed with 70% ethanol, -20°C, and then 
incubated for 30 minutes at room temperature or overnight 
at 4°C. Then, the residue was centrifuged (2,000 rpm 
for 3 minutes). The precipitated cells were washed with 
PBS for 2 times. Then, PI reagent was carefully added, 
and immediately homogenized. Microtubes containing 
cell suspension was then wrapped in aluminum foil and 
incubated in 37°C waterbath for 20 minutes. The cell 
suspension was homogenized and transferred back into 
the flow cytometer tube using nylon filters which was then 
ready to be analyzed by using flow cytometer.
Analysis of cell Apoptosis induction by Flow Cytometry 
As many as 5x105 cells/wells were grown in 6-well 
plates and then the cells were incubated until they got 
back to normal. The cells were treated with DMSO 
solvent (0.25%) and active isolates. The cells were 
then incubated for another 24 hours. At the end of the 
incubation period, the media was taken and transferred 
to centrifuge and decentrifuge (2,000 rpm, for 3 minutes) 
and then the supernatant was discarded. In wells where 
the medium had been taken, PBS was added, and it 
was then transferred to the same microtube from one 
treatment. Then it was centrifuged and the supernatant was 
discarded. This stage was repeated once more and then 
the cells were harvested with trypsin. Next, the cells were 
transferred into the same microtubes and then centrifuged 
(2,000 rpm for 3 minutes). The cell harvest residue 
left in the wells was washed with PBS and centrifuged 
again. Then the PBS was discarded. The residue was 
then carefully added with PI-Annexin V reagent, and 
immediately homogenized. Microtube containing cell 
suspension was wrapped in aluminum foil and incubated 
in 37°C waterbath for 5 minutes. The cell suspension 
was homogenized and then transferred back into the flow 
cytometer tube using nylon filters which then ready to be 
analyzed by using flow cytometer.
Analysis of caspase-8 by immunocytochemistry
24-well plates containing cell from the CO2 incubator 
were taken. Complete media from the well was removed 
with Pasteur pipette. PBS was added to the wells of 500 μL 
to wash the cells. PBS was removed with Pasteur pipette 
carefully. A sample of 1,000 μL was pipetted into 
the well. Complete media was added for cell control 
(2 cell controls). Cells were incubated in the CO2 
incubator. Cell incubation was stopped. The media from 
the wells are disposed and PBS was loaded at 500 μl 
into each well to wash the cells. Cover slips was taken 
using tweezers placed in a used 6-well plate and labeled 
on each treatment. Cold methanol (300 μl) was added 
and incubated for 10 minutes in freezer. Methanol was 
removed slowly, and prevent cover slip from reversing. 
If the staining is on the next day, then the cover slip was 
stored in freezer. PBS 500 μl was added to the cover slip 
and left for 5 minutes. PBS was removed and disposed. 
Cells were washed with PBS to rinse up the trace of 
methanol. A 500 μl of distilled water was added and 
left for 5 minutes. The distilled water was discardedand 
washed with distilled water 2 times. Solution of hydrogen 
peroxide (blocking solution) was dripped and incubated 
for 10 minutes. Prediluted blocking serum was dripped 
and incubated for 10 minutes. The solutionwere discarded. 
This process was done to prevent non-specific staining. 
Primary monoclonal anticaspase 8 antibody (C4106 
Sigma, monoclonal antibody caspase 8 031k4887, 
purified from hybridoma cell culture) was dripped and 
incubated for 5 minutes. PBS was discarded. Secondary 
antibodies were dropped and biotin labeled (biotinylated 
universal secondary antibody). Incubated for 10 minutes 
and 500 μl PBS was added, incubated for 5 minutes. 
PBS was discarded. Reagents containing peroxidase 
enzyme streptavidin complex was dripped and incubated 
for 10 min. PBS was added at 500 μl and incubated for 
5 minutes. PBS was discarded. DAB chromogen substrate 
solution was dripped, and incubated for 10 minutes. 
Aquadest at 500 μl was added and then discarded. 
Haematoxylin solution was dripped and incubated for 3 
minutes. Aquadest at 500 μl was added, and discarded. 
Cover slips were taken with tweezers carefully, and dipped 
in xylol. Cover slips dipped in alcohol. Cover slip was 
dipped. Cover slips were placed on top of glass object, 
dripped with mounting mediaand covered with square 
cover slip. Expression of caspase protein -8 was observed 
with a light microscope (CCRC, 2009).
Results
Isolation and Structural Analysis of Calotroposid A
Compound Isolation
Calotroposide A compound is a yellow amorphous 
crystalline isolate obtained from F2 separation of 
the roots of C.gigantea through three stages. In the first 
separation stage, column vacuum chromatography method 
was applied resulting seven sub-fractions i.e.: SF1-SF7. 
The cytotoxicity test results on SF1-SF7 showed that SF4 
had high anticancer activity with IC50 14.3 μg/ml. In the 
second phase, the separation process was performed on the 
sub-fractions SF4 using open column with stationary phase 
silica gel 60 and mobile phase solvent gradients which 
were the mixtures of hexane and ethyl acetate 4:1. Then, 
a mixture of ethyl acetate and chloroform 9:1 was used, 
continued with a mixture of chloroform and methanol 
1:1 and last methanol. From this separation process, five 
sub-fractions were produced i.e.: SF4.1, SF4.2, SF4.3, 
SF 4.4, and SF4.5. The results of cytotoxicity assay on 
SF4.1 to SF 4.5 showed that all sub-fractions had the 
potential to be anticancer agents with IC50 value below 
NCI (<20μg/ml) (Fadeyi et al, 2013). Next, the most 
active sub-fraction was selected, i.e.: sub-fraction 4.5 with 
the value of IC50 (3.49 μg/ml). The data on the cytotoxicity 
assay results on isolate SF4.1 to SF 4.5 can be seen in 
Table 1 as follows.
The data in the table above indicates that the IC50 
values of sub-fraction SF4.1 to SF4.5 had IC50 values 
below the value specified by the NCI. Thus, it can be stated 
that sub-fraction SF 4.1- 4.5 are effective as anticancer. 
From this study, in addition, the most active sub-fraction 
was selected which was sub-fraction SF 4.5.
Based on the test result and SF.4 separation result, 
isolate SF4.5 had been proven to provide higher 
anticancer activity (3.49 μg/ml) compared to the other 
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isolates. In addition, SF4.5 isolate weighed more than 
the other isolates, reaching 711.6 mg. Therefore, the next 
step is the isolate SF4.5 purification with preparatory 
chromatography method. From this isolation, isolate 4.5.1 
was formed which was an isolate dominated with intense 
purplish-blue color stain on visible observation, and dark 
brown color on the observation under UV366 light. Isolate 
4.5.1 was identified as Calotroposide A compound.
Compound Identification
The identification result by using TLC and HPLC 
showed that this compound was a compound with polar 
characteristic. The TLC identification with stationary 
phase: RP-18; and mobile phase: ACN: water (7:3) had 
shown Rf: 0.75. The result of UPLCMS/MS chromatogram 
indicated that Calotroposide A compound was extracted 
at the retention time (0.5 min). The compound’s ESIMS 
spectrum indicated molecular ion of m/z 1189.6490 (calcd 
for C63H96O21, 1188.6444) that matched to the molecular 
formula of m/z C63H96O21. These molecular ions were 
fragmented into m/z 684.2009; m/z 436.3346; m/z 
391.2794; m/z 182.9828; and m/z 141.9567.
The NMR-1H spectrum on the compound‘s aglycone 
showed three kinds of methyl on proton shear which 
were δ =1.86 (-CH3, 1H, Singlet); δ = 1.59 (-CH3, 1H, 
Singlet); δ = 1:04 (-CH3, 1H, Singlet). The occurring 
cyclohexane proton was δ=5:33 (-CH, 1H, Singlet). 
The characteristic of the benzene substituent occurrence 
on the compound was shown by proton signal at δ = 7.93/
C2’6 ‘(= CH benzene, 1H, double doublet); δ = 7.56; 
7.8/C3’C5 ‘(= CH benzene, 1H, triplet); δ = 7:46/C4 
‘(= CH benzene, 1H, triplet). A hydroxyl proton occurred 
at δ = 3.22 (OH, 1H, singlet).
Based on NMR-1H spectrum, this compound 
contained 5 types of oxypregnanane oligoglycoside 
sugars characterized with proton shear occurrence: 
5 anomeric signals, 5 methyl doublet signals and 
5 methoxy signals. The 5 anomeric spectrum signals 
were indicated by the proton shear at δ=4.75 (O-CH-O, 
1H, dd); =4.65 (O-CH-O, 1H, dd); =4.63 (O-CH-O, 1H, 
dd); =4.57 (O-CH-O, 1H, dd); =4.77 (O-CH-O, 1H, dd). 
The 5 methyl doublet spectrum signals were indicated by 
the proton shear at δ=1:04 (CH3 -CO; H3, doublet) δ=1.13 
(CH3 -CO; H3, doublet); δ=1.17 (CH3 -CO; H3, doublet); 
δ=1.19 (CH3 -CO; H3, doublet); δ=1.261 (CH3 -CO; H3, 
doublet). The 5 methoxy spectrum signals were indicated 
by a shift in the sugar protons at δ=3.40 (-OCH3, H3, 
Singlet); δ=3.32 (-OCH3, H3, Singlet), δ=3.40 (-OCH3, 
H3, Singlet); δ=3.40 (-OCH3, H3, Singlet); δ=3.40 
(-OCH3, H3, Singlet).
The compound molecular ion was m/z 1189.6490 that 
matched the molecular formula of m/z C63H96O21 while 
the proton shear at NMR-1H spectrum was identical with 
the Calotroposide H compound had been isolated from 
Figure 1. Chemical Structure of Isolate 4.5.1: Calotroposide A (Chemical Formula: C63H96O21)
Figure 2. The Induction Effect of Cell Death and Distribution Changes on Cell Cycle Phases on WiDr Cells Due to 
Calotroposid A Treatment at IC50 17.23 µg/ml. As many as 5x105 cells/well of WiDr cells were incubated for 24 hours and then treated with Calotroposide A on IC50. The distribution profile of each phase (Sub G1,G0-G1, S, and G2/M) 
in the cell cycle was analyzed using flow cytometry with propidium iodide staining (PI). 
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the roots of Calotropis procera. In addition, it was also 
identical with Calotroposide A electrically insulated from 
Calotropis gigantea (Ibrahim et al., 2015; Kitagawa et al., 
1992). The difference between Calotroposide H and A was 
that Calotroposide H was the epimer of Calotroposide 
A. Based on the species resemblance and also the 
similarity on molecular weight and proton shear, it can be 
concluded that this compound is a chemical compound of 
Calotroposide A. The chemical structure of Calotroposide 
A is presented in the figure below:
No ISOLAT Mean of Viability WiDr cells line (µg/mL) IC50 (µg/ml)*
1.79 3.58 6.25 12.5 25 50 100
1 Calotroposid A 92.24 74.66 78.08 67.58 47.95 12.33 17.58 17.23±0.03
*, The average value of IC50 ± standard deviation with three replication
Mean of Viability WiDr cells line (%)*± SD
Isolate / Dosis 0.78125 µg 1.56 µg 3.125 µg 6.25 µg 12.5 µg 25 µg 50 µg IC50**± SD(µg/ml)
SF4.1 (isolate 1) 80.55 ± 5.72 76.87 ± 5.15 65.66 ± 2.78 54.75 ± 2.03 48.3 ± 3.3 37.45 ± 1 24.1 ± 1.86 9.41 ± 1.69
SF4.2 (isolate 2) 83.55 ± 2.69 70.32 ± 0.73 61.6 ± 0.89 50.75 ± 2.36 40.3 ± 1.79 25.45 ± 3.23 14.1 ± 1.43 6.01 ± 0.74
SF4.3 (isolate 3) 86.22 ± 0.4 72.12 ± 0.99 60.2 ± 0.78 40.74 ± 0.53 37.32 ± 1.18 28.45 ± 2.3 13.3 ± 1.56 5.65 ± 0.22
SF4.4 (isolate 4) 87.43 ± 1.14 76.43 ± 0.16 56.83 ± 1.48 45.36 ± 1.06 37.65 ± 2.21 21.45 ± 3.28 1.3 ± 0.98 5.53 ± 0.53
SF4.5 (isolate 5) 76.52 ± 1.29 64.39 ± 2.06 51.23 ± 2.02 38.51 ± 0.03 28.35 ± 1.8 19.2 ± 0.76 9.32 ± 0.65 3.49 ± 0.22
Table 1. Values of IC50 of SF4.1-SF 4.5 Treatments on the Growth of WiDr Colon Cancer Cells
*, The average value of Viability (%) ± standard deviation with three replication; **, The average value of IC50 ± standard deviation with three 
replication
Table 2. Average Percentage of WiDr Colon Cancer Cells Viability as a Result of Isolate Calotroposid A Treatment
Figure 3 . The Results of Cell Distribution and Induction Analysis of Cell Death/ Cell Quest by using Flow Cytometry 
(A) WiDr Control Cells (B) Calotroposid A Treatment on WiDr Cells; (R1) Living Cells, (R2) Early Apoptosis, (R3) 
Late Apoptosis and (R4) Necrosis.
Figure 4. The Treatment Effects of Calotroposide A Compound on Caspase-8 Expression on WiDr Cells. WiDr Cells 
with (5x10 4) density were incubated on coverslips in 12 well plates for 24 hours to adapt. Then, Calotroposid A 
compound was treated on IC50 17.23 μg/ml, and then incubated for another 15 hours while caspase-8 staining was conducted using immunocytochemistry method in accordance with the research procedure. (A) cell control without 
caspase-8 antibody, (B) cells with Calotroposide A compound treatment with anti-caspase-8 antibody indicated an 
increase on caspase-8 protein expression as seen from the cytosol brown stain. The arrow (b) indicates caspase-8 
expression. The microscope used was a light microscope with 400x magnification.
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In vitro Assay of Calotroposid A Anticancer Compound
An in vitro anticancer activity test was conducted on 
Calotroposide A compound towards WiDr cancer cells by 
using MTT assay method. The activity test results showed that 
the increase on the concentration of the tested Calotroposid 
A compound might induce a decrease in WiDr cell 
viability. To identify the potential barriers of Calotroposide 
A compound growth, IC50 value was calculated by using 
probit analysis. The probit analysis result recapitulation 
can be seen in Table 2 below.
Based on the data in the table above, it can be indicated 
that the IC50 value of isolate Calotroposide A was below 
the value specified by the NCI. Thus, it can be stated that 
isolate Calotroposide A may be effective as anticancer.
Apoptosis Induction Mechanism
The Regulation Test Results of WiDr Cancer Cell Cycle 
due to Calotroposide A Isolate Treatment
Cell Cycle analysis by using flow cytometri showed 
that treatment of 17.23 µg/ml Calotroposid A for 
24 h caused increasing of sub-G1, S-phase and G2-M 
accumulation until 14.84%, 21.51% and 15.03% 
respectively compared to control cells (Figure 3A-B). 
The High cells accumulation on sub-G1 represents the 
death cells. 
The Induction Test Results of WiDr Cancer Cell Apoptosis 
due to Isolate Calotroposid A Treatment
On the cell apoptosis analysis results induced by 
Calotroposide A compound treatment on WiDr cancer 
cells, it can be seen that early apoptotic cells increased 
by 11.62%, with 1.27% of late apoptosis while necrosis 
declined by 0.71%. The increase in cell apoptosis was 
also correlated with increased cells accumulation in 
sub-G1 phase (Figure. 4A-B; Figure. 3A-B). Cytotoxic 
activity of isolate calotroposid A possibly through 
inducing of apoptosis and cells cycle accumulation in 
S-phase and G2/M-phase.
Figure 5. The Relationship between Calotroposide A and Cytotoxic Activity (modified from (Juncker et al., 2009))
The Analysis Results of Caspase-8 Protein Expression 
of WiDr Cells on Calotroposide A Compound Treatment
The immunocytochemistry test results indicated that 
the Calotroposide A treatment on IC50 17.23μg/ml on 
WiDr cancer cells had caused an increase on caspase-8 
protein expression amounted to 18.8% compared to 
the control group. The increase on caspase-8 protein 
expression can be seen from the brown in the cytosol. 
The immunocytochemistry assay results on Calotroposide 
A treatment is presented in the figure below:
Discussion
Anticancer activity and the operating mechanism of 
Calotroposide A compound on WiDr cells is still unknown 
by previous research. Calotroposid A compound is 
a terpenoid glycoside compound consisting of aglycone 
part in form of terpenoid core structure and glycone part are 
composed of five sugar of cymarosa-cymarosa-oleandrosa-
oleandrosa-cymarosa. Calotroposid A compound and its 
epimer i.e.: Calotroposide H has been found by previous 
researchers to be inactive in vitro on A549 NSCLC cells 
(IC50: 3.3μM), U 373 GBM cells (IC50:21.8 m) and prostate 
cancer cells PC-3 (IC50:17.6μM) (Ibrahim et al, 2015).
From the results of this study, it was indicated 
that Calotroposide A compound was proven to induce 
anticancer activity towards WiDr colon cancer cells with 
IC50:17.23 μg/ml. Based on the data of cell cycle regulation 
tests of cell apoptosis induction and caspase 8 expression, 
it could be explained that the Calotroposide A compound 
treatment towards the proliferation of WiDr colon cancer 
cells had led to an increase in S phase, G2/M phase 21.51% 
and 15.03%. As a result of these improvements, cancer 
cell apoptosis increased. In molecular level, the indicator 
of cell apoptosis increase was the occurrence of caspase 
8 expression increased.
Considering the chemical structure, Calotroposide A is 
a triterpenoid glycoside compound. The amount of sugars 
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in the aglycone part has affected the anticancer activity, 
where the more sugar chain built, the more the activities 
increase (Juncker et al., 2009). The pharmacophore 
group of this compound is suspected to be in atom C 
number 12, i.e.: benzoate and methyl groups on atom 
C number 19. The structure of active Calotroposide A 
compound and its pharmacophore group are presented in 
the figure below.
The glycone part on Calotroposide A compound 
serves to increase the solubility of aglycone part in 
body fluids, where body fluids are composed of 80% 
water which is a polar compound. Calotroposide A 
solubility increase in body fluids will increase the speed 
compound distribution to achieve network/target cell. 
The pharmacore group in the aglycone of Calotroposide 
A compound is capable of inducing apoptosis through the 
activation of death receptor (CD 95/Fas). The activation of 
Fas by Fas ligand (FasL) affects caspase-8 activation. 
Furthermore, caspase-8 breaks the inactive form of 
the Bid into two parts which are the part containing 
BH3 domain as an active form of Bid (tBid). The tBid 
Protein in translocation to the mitochondria stimulates 
the release of Cyt c which then forms a complex with 
Apaf-2. This complex further activates caspase-9 and 
caspase-7, and thus, the apoptosis induction takes place. 
The caspase-9 activation also leads to caspase-3 activation, 
followed by the caspase-2 activation. The increased 
activation of caspase-2 will trigger the G2/M checkpoint 
maintenance. The G2-phase checkpoint is a very important 
phase in ensuring the accuracy of DNA replication and 
division which prepares genomes into daughter cells. 
If inaccuracy occurs in DNA replication, there will be 
apoptosis induction. The increasing number of cells in 
G2/M phase of the normal DNA replication indicates 
the increase of inaccuracy, and thus, the number of cells 
undergoing apoptosis also increases (Cullen and Martin, 
2009).
In conclusion, calotroposide A compound is 
capable of inhibiting the growth of WiDr colon cancer 
cells in IC50:17.23 μg/ml through apoptosis induction 
and increased expression of caspase-8. 
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